相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bile Acids and Nonalcoholic Fatty Liver Disease: Molecular Insights and Therapeutic Perspectives
Juan P. Arab et al.
HEPATOLOGY (2017)
Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis
Gloria Alvarez-Sola et al.
DIGESTIVE DISEASES (2017)
Obeticholic acid for the treatment of primary biliary cirrhosis
Palak J. Trivedi et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
FXR blocks the growth of liver cancer cells through inhibiting mTOR-s6K pathway
Xiongfei Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Bile acids and FGF receptors: orchestrators of optimal liver regeneration
Helene Gilgenkrantz et al.
GUT (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Farnesoid X receptor associates with β-catenin and inhibits its activity in hepatocellular carcinoma
Xijun Liu et al.
ONCOTARGET (2015)
Knocking on FXR's Door: The Hammerhead-Structure Series of FXR Agonists - Amphiphilic Isoxazoles with Potent In Vitro and In Vivo Activities
Christian Gege et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Mechanisms of STAT3 activation in the liver of FXR knockout mice
Guodong Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Cellular and molecular mechanisms of hepatocellular carcinoma: an update
Rajagopal N. Aravalli et al.
ARCHIVES OF TOXICOLOGY (2013)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice
Guodong Li et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Downregulation of nuclear receptor FXR is associated with multiple malignant clinicopathological characteristics in human hepatocellular carcinoma
Hongying Su et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
FXR ligands protect against hepatocellular inflammation via SOCS3 induction
Zhizhen Xu et al.
CELLULAR SIGNALLING (2012)
Hepatocarcinogenesis in FXR-/- Mice Mimics Human HCC Progression That Operates through HNF1α Regulation of FXR Expression
Nian Liu et al.
MOLECULAR ENDOCRINOLOGY (2012)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist
Giovanni Rizzo et al.
MOLECULAR PHARMACOLOGY (2010)
Hepatocellular Carcinoma: Epidemiology, Surveillance, and Diagnosis
Morris Sherman
SEMINARS IN LIVER DISEASE (2010)
Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling
Katryn Allen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice
Insook Kim et al.
CARCINOGENESIS (2007)
Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor
Fan Yang et al.
CANCER RESEARCH (2007)
Absolute quantitation of RNA by a competitive real-time RT-PCR method using piscine nodavirus as a model
S Grove et al.
JOURNAL OF VIROLOGICAL METHODS (2006)
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
YQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
The Farnesoid X receptor - A molecular link between bile acid and lipid and glucose metabolism
T Claudel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity
GL Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
SOCS3 negatively regulates IL-6 signaling in vivo
BA Croker et al.
NATURE IMMUNOLOGY (2003)
6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction
S Fronhoffs et al.
MOLECULAR AND CELLULAR PROBES (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
B Goodwin et al.
MOLECULAR CELL (2000)
分享论文
